Does polycystic ovary syndrome increase the disparity in metabolic syndrome and cardiovascular-related health for African-American women?

Seminars in Reproductive Medicine

Volumn 26, Issue 1, 2008, Pages 35-38

  Coney, PonJola ^a,c   Ladson, Gwinnett ^a   Sweet, Stephanie ^a   Legro, Richard S ^b  

^a MEHARRY MEDICAL COLLEGE   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Metabolic risk; Minority women's health; Polycystic ovaries

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; FEMALE; HIGH RISK POPULATION; HUMAN; INCIDENCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MORTALITY; OBESITY; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PREVALENCE; RACE DIFFERENCE; RISK FACTOR;

AFRICAN AMERICANS; CARDIOVASCULAR DISEASES; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; METABOLIC SYNDROME X; POLYCYSTIC OVARY SYNDROME; PREVALENCE; RISK FACTORS;

EID: 38149090181     PISSN: 15268004     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-992922     Document Type: Article

References (18)

1. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25
2. Dunaif A. Insulin action in the polycystic ovary syndrome. Endocrinol Metab Clin North Am 1999;28:341-359
3. Dunaif A. Current concepts in the polycystic ovary syndrome. Annu Rev Med 2001;52:401-419
4. Moller DE, Kaufman KD. Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med 2005;56:45-62
5. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endorinol Metab 1998;83:3078-3082
6. Hoyert DL, Heron MP, Murphy SL, Kung HC. Deaths: final data for 2003. Natl Vital Stat Rep 2006;54:1-120
7. Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health CareWashington, DC: National Academy of Sciences; 2002
8. Mensah GA, Mokdad AH, Ford ES, Greenlund KJ, Croft JB. State of disparities in cardiovascular health in the United States. Circulation 2005;111:1233-1241
9. Finkelstein EA, Khavjou MA, Mobley LR, Haney DM, Will JC. Racial/ethic disparities in coronary heart disease risk factors among WISEWOMAN enrollees. J Womens Health 2004;13:503-518
10. Welt CK, Arason G, Gudmundsson JA, et al. Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations. J Clin Endocrinol Metab 2006;91:4361-4368
11. Dokras A, Bochner M, Hollinrake E, Markham S, VanVoorhis B, Jagasia DH. Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet Gynecol 2005;106:131-137
12. Legro RS, Myers ER, Barnhart HX, et al, for the the Reproductive Medicine Network. The Pregnancy in Polycystic Ovary Syndrome Study: baseline characteristics of the randomized cohort including racial effects. Fertil Steril 2006;86:914-933
13. Carnethon MR, Loria CM, Hill JO, Sidney S, Savage PJ, Liu K. Risk factors for the metabolic syndrome: the Coronary Artery Risk Development in Young Adults (Cardia) study, 1985-2001. Diabetes Care 2004;27:2707
14. Coviello AD, Legro RS, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab 2006;91:492-497
15. Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN. for the PCOS/Troglitazone Study Group. Prevalence and predictors of the metabolic syndrome in women with PCOS. J Clin Endocrinol Metab 2006;91:48-53
16. Holte J, Bergh T, Berne C, et al. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 1995;80:2586-2593
17. Palaniappan LP, Kwan AC, Abbasi F, Lamendola C, McLaughlin TL, Reaven GM. Lipoprotein abnormalities are associated with insulin resistance in South Asian Indian women. Metabolism 2007;56:899-904
18. Chen MJ, Yang WS, Yang JH, Chen CL, Ho HN, Yang YS. Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome. Hypertension 2007;49:1442-1447